Evaluation of the Efficacy, Tolerability and Safety of Etoricoxib (Arcoxia) in Patients With Neuropathic Pain
Status:
Unknown status
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
The present study will aim to determine the safety, efficacy, and tolerability of etoricoxib,
an NSAID pain reliever, in patients with Neuropathic pain. Neuropathic pain, or pain caused
by abnormal activity of sensory neurons, remains undertreated. Post herpetic neuralgia (PHN),
which is commonly referred to as post-shingles pain, is the most useful disease to study when
investigating the efficacy of pain relievers for Neuropathic pain. Therefore, this study will
primarily involve patients with PHN.
The hypothesis in this study is that etoricoxib efficacy is superior to that of placebo.